Tapewire

Nasdaq · USD

HCWB

HCW Biologics Inc.

Export transactions ↓
Tapewire entity
8172
SEC CIK
0001828673
Parsed reports
109

Last 12 months

Inside the activity.

6 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202630
Jun 202600
Jul 202630
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 14, 2022 Filed Jun 15, 2022 23:13 UTC
Byam RebeccaChief Financial Officer
PurchaseCommon Stock 58,856 $2.46 $144,985.87
Disclosure

SEC source: 0001209191-22-037110 · doc4.xml · nonDerivative · entry 2

Byam Rebecca · CIK 0001866256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,452

F2 · price: The range of prices for the shares of Common Stock is from $2.01 to $2.66. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
June 13, 2022 Filed Jun 15, 2022 23:13 UTC
Byam RebeccaChief Financial Officer
PurchaseCommon Stock 7,596 $2.08 $15,812.59
Disclosure

SEC source: 0001209191-22-037110 · doc4.xml · nonDerivative · entry 1

Byam Rebecca · CIK 0001866256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,596

F1 · price: The range of prices for the shares of Common Stock is from $1.99 to $2.2. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
June 10, 2022 Filed Jun 11, 2022 00:03 UTC
Winer Gary MDirector
PurchaseCommon Stock 1,500 $2.13 $3,199.95
Disclosure

SEC source: 0001209191-22-036153 · doc4.xml · nonDerivative · entry 3

Winer Gary M · CIK 0001822095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

F1 · price: The range of prices for the shares of Common Stock is from $2.10 to $2.15. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 21:16 UTC
Wong Hing CDirector · Chief Executive Officer
PurchaseCommon Stock 1,520 $2.19 $3,325.76
Disclosure

SEC source: 0001209191-22-036395 · doc4.xml · nonDerivative · entry 1

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,286,468

F1 · price: The range of prices for the shares of Common Stock is from $2.115 to $2.2301. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
June 09, 2022 Filed Jun 9, 2022 21:59 UTC
Wong Hing CDirector · Chief Executive Officer
PurchaseCommon Stock 2,000 $2.25 $4,490.00
Disclosure

SEC source: 0001209191-22-035554 · doc4.xml · nonDerivative · entry 2

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,284,948

F1 · price: The range of prices for the shares of Common Stock is from $2.24 to $2.25. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
June 09, 2022 Filed Jun 11, 2022 00:03 UTC
Winer Gary MDirector
PurchaseCommon Stock 1,000 $2.20 $2,200.00
Disclosure

SEC source: 0001209191-22-036153 · doc4.xml · nonDerivative · entry 2

Winer Gary M · CIK 0001822095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,500

Read SEC document
June 08, 2022 Filed Jun 11, 2022 00:03 UTC
Winer Gary MDirector
PurchaseCommon Stock 1,000 $2.27 $2,272.70
Disclosure

SEC source: 0001209191-22-036153 · doc4.xml · nonDerivative · entry 1

Winer Gary M · CIK 0001822095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

Read SEC document
June 07, 2022 Filed Jun 8, 2022 20:45 UTC
Winer Gary MDirector
PurchaseCommon Stock 1,000 $2.10 $2,100.00
Disclosure

SEC source: 0001209191-22-035060 · doc4.xml · nonDerivative · entry 2

Winer Gary M · CIK 0001822095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,500

Read SEC document
June 07, 2022 Filed Jun 9, 2022 21:59 UTC
Wong Hing CDirector · Chief Executive Officer
PurchaseCommon Stock 1,000 $2.31 $2,310.00
Disclosure

SEC source: 0001209191-22-035554 · doc4.xml · nonDerivative · entry 1

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,282,948

Read SEC document
June 06, 2022 Filed Jun 8, 2022 20:45 UTC
Winer Gary MDirector
PurchaseCommon Stock 1,000 $2.13 $2,127.30
Disclosure

SEC source: 0001209191-22-035060 · doc4.xml · nonDerivative · entry 1

Winer Gary M · CIK 0001822095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,500

Read SEC document
June 02, 2022 Filed Jun 6, 2022 16:16 UTC PurchaseCommon Stock 4,800 $2.09 $10,040.64
Disclosure

SEC source: 0001209191-22-034510 · doc4.xml · nonDerivative · entry 1

Greene Rick S. · CIK 0001866272 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,411

F1 · price: The range of prices for the shares of Common Stock is from $2.02 to $2.10. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 16:16 UTC
Jiao Jin-anVP of Development
Exercise / conversionStock Option (Right to Buy) · Derivative 1,714 $0.00 Strike: $0.21 $0.00
Disclosure

SEC source: 0001209191-22-033517 · doc4.xml · derivative · entry 4

Jiao Jin-an · CIK 0001866271 · VP of Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,857

Underlying: Common Stock · 1,714 shares

Expires 2030-12-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 20% of the total shares subject to the stock option grant will vest on December 22, 2021; 20% of the total shares subject to the stock option grant will vest on December 22, 2022; 25% of the total shares subject to the stock option grant will vest on December 22, 2023; and 35% of the total shares subject to the stock option grant will vest on December 22, 2024.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 16:16 UTC
Jiao Jin-anVP of Development
Exercise / conversionStock Option (Right to Buy) · Derivative 12,856 $0.00 Strike: $0.14 $0.00
Disclosure

SEC source: 0001209191-22-033517 · doc4.xml · derivative · entry 3

Jiao Jin-an · CIK 0001866271 · VP of Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,001

Underlying: Common Stock · 12,856 shares

Expires 2029-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These option shares were part of a stock option grant covering 51,428 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant will vest on May 30, 2022; and 35% of the total shares subject to the stock option grant will vest on May 30, 2023.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 16:16 UTC
Jiao Jin-anVP of Development
Exercise / conversionCommon Stock 1,714 $0.21 $359.94
Disclosure

SEC source: 0001209191-22-033517 · doc4.xml · nonDerivative · entry 2

Jiao Jin-an · CIK 0001866271 · VP of Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 16:16 UTC
Jiao Jin-anVP of Development
Exercise / conversionCommon Stock 12,856 $0.14 $1,799.84
Disclosure

SEC source: 0001209191-22-033517 · doc4.xml · nonDerivative · entry 1

Jiao Jin-an · CIK 0001866271 · VP of Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 17:42 UTC
Rhode PeterSee Remarks
Exercise / conversionStock Option Grant (Right to Buy) · Derivative 1 $0.00 Strike: $0.14 $0.00
Disclosure

SEC source: 0001209191-22-003785 · doc4.xml · derivative · entry 4

Rhode Peter · CIK 0001866276 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,427

Underlying: Common Stock · 1 shares

Expires 2029-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These option shares were part of a stock option grant covering 85,713 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant will vest on May 30, 2022; and 35% of the total shares subject to the stock option grant will vest on May 30, 2023, subject to the reporting person's continuous service through the applicable vesting date.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 17:42 UTC
Rhode PeterSee Remarks
Exercise / conversionStock Option Grant (Right to Buy) · Derivative 1,714 $0.00 Strike: $0.21 $0.00
Disclosure

SEC source: 0001209191-22-003785 · doc4.xml · derivative · entry 3

Rhode Peter · CIK 0001866276 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,857

Underlying: Common Stock · 1,714 shares

Expires 2030-12-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 20% of the total shares subject to the stock option grant vested on December 22, 2021; 20% of the total shares subject to the stock option grant will vest on December 22, 2022; 25% of the total shares subject to the stock option grant will vest on December 22, 2023; and 35% of the total shares subject to the stock option grant will vest on December 22, 2024, subject to the reporting person's continuous service through the applicable vesting date.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 17:42 UTC
Rhode PeterSee Remarks
Exercise / conversionCommon Stock 1 $0.14 $0.14
Disclosure

SEC source: 0001209191-22-003785 · doc4.xml · nonDerivative · entry 2

Rhode Peter · CIK 0001866276 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 17:42 UTC
Rhode PeterSee Remarks
Exercise / conversionCommon Stock 1,714 $0.21 $359.94
Disclosure

SEC source: 0001209191-22-003785 · doc4.xml · nonDerivative · entry 1

Rhode Peter · CIK 0001866276 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2021 Filed Dec 7, 2021 12:31 UTC
Jiao Jin-anVP of Development
PurchaseCommon Stock 10,000 $2.42 $24,150.00
Disclosure

SEC source: 0001209191-21-068274 · doc4.xml · nonDerivative · entry 1

Jiao Jin-an · CIK 0001866271 · VP of Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,571

F1 · price: The range of prices for the shares of Common Stock is from $2.40 to $2.43. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:10 UTC
Flowers LeeSVP of Business Development
Exercise / conversionStock Option (Right to Buy) · Derivative 4,285 $0.00 Strike: $0.14 $0.00
Disclosure

SEC source: 0001209191-21-067740 · doc4.xml · derivative · entry 2

Flowers Lee · CIK 0001866254 · SVP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,857

Underlying: Common Stock · 4,285 shares

Expires 2029-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:10 UTC
Flowers LeeSVP of Business Development
Exercise / conversionCommon Stock 4,285 $0.14 $599.90
Disclosure

SEC source: 0001209191-21-067740 · doc4.xml · nonDerivative · entry 1

Flowers Lee · CIK 0001866254 · SVP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 17:17 UTC
Byam RebeccaChief Financial Officer
Exercise / conversionStock Option Grant (Right to Buy) · Derivative 27,000 $0.00 Strike: $0.14 $0.00
Disclosure

SEC source: 0001209191-21-066900 · doc4.xml · derivative · entry 2

Byam Rebecca · CIK 0001866256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,999

Underlying: Common Stock · 27,000 shares

Expires 2029-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These option shares were part of a stock option grant covering 135,000 shares of common stock. 20% of the total shares subject to the stock option grant vested on October 10, 2020; 20% of the total shares subject to the stock option grant vested on October 10, 2021; 25% of the total shares subject to the stock option grant will vest on October 10, 2022; and 35% of the total shares subject to the stock option grant will vest on October 10, 2023, subject to her continuous service through the applicable vesting date. The option is subject to additional vesting acceleration pursuant to her Employment Agreement.

Read SEC document
November 23, 2021 Filed Nov 26, 2021 17:17 UTC
Byam RebeccaChief Financial Officer
Exercise / conversionCommon Stock 27,000 $0.14 $3,780.00
Disclosure

SEC source: 0001209191-21-066900 · doc4.xml · nonDerivative · entry 1

Byam Rebecca · CIK 0001866256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 26, 2021 Filed Oct 28, 2021 17:12 UTC GrantStock Option · Derivative 37,037 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-21-061922 · doc4.xml · derivative · entry 1

Giles Lisa M. · CIK 0001568850 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,037

Underlying: Common Stock · 37,037 shares

Expires 2031-10-25

F1 · derivative.exercise_date: The option will fully vest on October 26, 2022.

Read SEC document
October 26, 2021 Filed Oct 29, 2021 00:14 UTC Amendment
Winer Gary MDirector
GrantStock Option · Derivative 37,037 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-21-061979 · doc4a.xml · derivative · entry 1

Winer Gary M · CIK 0001822095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,037

Underlying: Common Stock · 37,037 shares

Expires 2031-10-25

F1 · derivative.exercise_date: The option will fully vest on October 26, 2022.

Read SEC document
October 26, 2021 Filed Oct 28, 2021 21:14 UTC
Winer Gary MDirector
GrantStock Option · Derivative 30,037 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001209191-21-061923 · doc4.xml · derivative · entry 1

Winer Gary M · CIK 0001822095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,037

Underlying: Common Stock · 30,037 shares

Expires 2031-10-25

F1 · derivative.exercise_date: The option will fully vest on October 26, 2022.

Read SEC document
September 15, 2021 Filed Sep 17, 2021 17:12 UTC OtherCommon Stock 3,587,659 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-056677 · doc4.xml · nonDerivative · entry 1

Medmira Capital Ltd. · CIK 0001872543 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Pro-rata in-kind stock distribution to its members or member's designee for no consideration.

Read SEC document
September 08, 2021 Filed Sep 10, 2021 17:48 UTC
Rhode PeterSee Remarks
GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $4.31 $0.00
Disclosure

SEC source: 0001209191-21-055530 · doc4.xml · derivative · entry 1

Rhode Peter · CIK 0001866276 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-09-07

F1 · derivative.exercise_date: The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.

Read SEC document
September 08, 2021 Filed Sep 10, 2021 21:46 UTC
Flowers LeeSVP of Business Development
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $4.31 $0.00
Disclosure

SEC source: 0001209191-21-055528 · doc4.xml · derivative · entry 1

Flowers Lee · CIK 0001866254 · SVP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-09-07

F1 · derivative.exercise_date: The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.

Read SEC document
September 08, 2021 Filed Sep 10, 2021 21:44 UTC
Wong Hing CDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 800,000 $0.00 Strike: $4.31 $0.00
Disclosure

SEC source: 0001209191-21-055525 · doc4.xml · derivative · entry 1

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2031-09-07

F1 · derivative.exercise_date: The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.

Read SEC document
September 08, 2021 Filed Sep 10, 2021 21:52 UTC
Byam RebeccaChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 80,000 $0.00 Strike: $4.31 $0.00
Disclosure

SEC source: 0001209191-21-055531 · doc4.xml · derivative · entry 2

Byam Rebecca · CIK 0001866256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2031-09-07

F2 · derivative.exercise_date: The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.

Read SEC document
September 08, 2021 Filed Sep 10, 2021 17:45 UTC
Jiao Jin-anVP of Development
GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $4.31 $0.00
Disclosure

SEC source: 0001209191-21-055527 · doc4.xml · derivative · entry 1

Jiao Jin-an · CIK 0001866271 · VP of Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-09-07

F1 · derivative.exercise_date: The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.

Read SEC document
August 31, 2021 Filed Sep 2, 2021 22:15 UTC
Wong Hing CDirector · Chief Executive Officer
PurchaseCommon Stock 3,830 $3.93 $15,070.28
Disclosure

SEC source: 0001209191-21-054545 · doc4.xml · nonDerivative · entry 1

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,277,948

F1 · price: The range of prices for the shares of Common Stock is from $3.91 to $3.97. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 31, 2021 Filed Oct 7, 2021 23:18 UTC Amendment
Wong Hing CDirector · Chief Executive Officer
PurchaseCommon Stock 5,830 $3.94 $22,970.20
Disclosure

SEC source: 0001209191-21-059989 · doc4a.xml · nonDerivative · entry 1

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,281,948

F1 · price: The range of prices for the shares of Common Stock is from $3.91 to $3.97. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 30, 2021 Filed Aug 30, 2021 23:41 UTC
Wong Hing CDirector · Chief Executive Officer
PurchaseCommon Stock 6,000 $3.93 $23,599.80
Disclosure

SEC source: 0001209191-21-053958 · doc4.xml · nonDerivative · entry 3

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,274,118

F3 · price: The range of prices for the shares of Common Stock is from $3.91 to $3.96. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 29, 2021 Filed Sep 10, 2021 21:52 UTC
Byam RebeccaChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 135,000 $0.00 Strike: $4.00 $0.00
Disclosure

SEC source: 0001209191-21-055531 · doc4.xml · derivative · entry 1

Byam Rebecca · CIK 0001866256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,000

Underlying: Common Stock · 135,000 shares

Expires 2031-08-28

F1 · derivative.exercise_date: The option will vest as follows: 33% will vest on July 22, 2022, 33% will vest on July 22, 2023 and 34% will vest on July 22, 2024.

Read SEC document
August 27, 2021 Filed Aug 30, 2021 23:41 UTC
Wong Hing CDirector · Chief Executive Officer
PurchaseCommon Stock 6,000 $3.77 $22,620.00
Disclosure

SEC source: 0001209191-21-053958 · doc4.xml · nonDerivative · entry 2

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,268,118

F2 · price: The range of prices for the shares of Common Stock is from $3.74 to $3.83. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 27, 2021 Filed Oct 7, 2021 23:17 UTC Amendment
Wong Hing CDirector · Chief Executive Officer
PurchaseCommon Stock 8,000 $3.76 $30,100.00
Disclosure

SEC source: 0001209191-21-059988 · doc4a.xml · nonDerivative · entry 1

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,270,118

F1 · price: The range of prices for the shares of Common Stock is from $3.74 to $3.83. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 26, 2021 Filed Aug 30, 2021 23:41 UTC
Wong Hing CDirector · Chief Executive Officer
PurchaseCommon Stock 6,500 $3.84 $24,969.75
Disclosure

SEC source: 0001209191-21-053958 · doc4.xml · nonDerivative · entry 1

Wong Hing C · CIK 0001866258 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,262,118

F1 · price: The range of prices for the shares of Common Stock is from $3.80 to $3.89. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 25, 2021 Filed Aug 27, 2021 16:42 UTC PurchaseCommon Stock 3,611 $4.10 $14,821.35
Disclosure

SEC source: 0001209191-21-053633 · doc4.xml · nonDerivative · entry 1

Greene Rick S. · CIK 0001866272 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,611

F1 · price: The range of prices for the shares of Common Stock is from $4.09 to $4.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 23, 2021 Filed Aug 24, 2021 21:05 UTC
Flowers LeeSVP of Business Development
PurchaseCommon Stock 5,605 $3.95 $22,156.57
Disclosure

SEC source: 0001209191-21-053170 · doc4.xml · nonDerivative · entry 2

Flowers Lee · CIK 0001866254 · SVP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,667

Read SEC document
August 20, 2021 Filed Aug 24, 2021 21:05 UTC
Flowers LeeSVP of Business Development
PurchaseCommon Stock 7,853 $4.08 $32,069.30
Disclosure

SEC source: 0001209191-21-053170 · doc4.xml · nonDerivative · entry 1

Flowers Lee · CIK 0001866254 · SVP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,062

F1 · price: The range of prices for the shares of Common Stock is from $4.06 to $4.166. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 19, 2021 Filed Aug 23, 2021 23:53 UTC
Flowers LeeSVP of Business Development
PurchaseCommon Stock 10,532 $4.25 $44,785.22
Disclosure

SEC source: 0001209191-21-053050 · doc4.xml · nonDerivative · entry 1

Flowers Lee · CIK 0001866254 · SVP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,209

F1 · price: The range of prices for the shares of Common Stock is from $4.2519 to $4.27. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 19, 2021 Filed Aug 23, 2021 23:50 UTC
Byam RebeccaChief Financial Officer
PurchaseCommon Stock 10,000 $4.40 $43,979.00
Disclosure

SEC source: 0001209191-21-053049 · doc4.xml · nonDerivative · entry 1

Byam Rebecca · CIK 0001866256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,000

Read SEC document
August 19, 2021 Filed Aug 24, 2021 21:01 UTC Amendment
Flowers LeeSVP of Business Development
PurchaseCommon Stock 10,532 $4.29 $45,218.09
Disclosure

SEC source: 0001209191-21-053163 · doc4a.xml · nonDerivative · entry 1

Flowers Lee · CIK 0001866254 · SVP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,209

F1 · price: The range of prices for the shares of Common Stock is from $4.293 to $4.31 The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
August 19, 2021 Filed Sep 10, 2021 21:53 UTC Amendment
Byam RebeccaChief Financial Officer
PurchaseCommon Stock 10,000 $4.40 $43,979.00
Disclosure

SEC source: 0001209191-21-055532 · doc4a.xml · nonDerivative · entry 1

Byam Rebecca · CIK 0001866256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,000

F1 · price: The range of prices for the shares of Common Stock is from $4.17 to $4.68. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.

Read SEC document
July 22, 2021 Filed Jul 23, 2021 19:32 UTC ConversionSeries C Redeemable Preferred Stock · Derivative 730,519 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-048086 · doc4.xml · derivative · entry 4

Medmira Capital Ltd. · CIK 0001872543 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 730,519 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.

F2 · derivative.exercise_date: Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.

F2 · derivative.expiration_date: Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.

Read SEC document
July 22, 2021 Filed Jul 23, 2021 19:32 UTC ConversionSeries B Redeemable Preferred Stock · Derivative 2,857,142 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-048086 · doc4.xml · derivative · entry 3

Medmira Capital Ltd. · CIK 0001872543 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,857,142 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date.

Read SEC document
July 22, 2021 Filed Jul 23, 2021 19:32 UTC ConversionCommon Stock 730,519 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-048086 · doc4.xml · nonDerivative · entry 2

Medmira Capital Ltd. · CIK 0001872543 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,587,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.